iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Means Investment CO. Inc.


Share on StockTwits

Means Investment CO. Inc. grew its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 8.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,124 shares of the financial services provider’s stock after purchasing an additional 378 shares during the period. Means Investment CO. Inc.’s holdings in iShares Nasdaq Biotechnology ETF were worth $771,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Wade G W & Inc. increased its holdings in shares of iShares Nasdaq Biotechnology ETF by 234.8% in the fourth quarter. Wade G W & Inc. now owns 7,617 shares of the financial services provider’s stock valued at $1,154,000 after purchasing an additional 5,342 shares during the period. FWL Investment Management LLC acquired a new position in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter valued at approximately $2,644,000. AlphaStar Capital Management LLC increased its holdings in shares of iShares Nasdaq Biotechnology ETF by 9.6% in the fourth quarter. AlphaStar Capital Management LLC now owns 5,597 shares of the financial services provider’s stock valued at $905,000 after purchasing an additional 490 shares during the period. Rye Brook Capital LLC acquired a new position in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter valued at approximately $6,035,000. Finally, Bard Financial Services Inc. acquired a new position in shares of iShares Nasdaq Biotechnology ETF in the fourth quarter valued at approximately $4,124,000. 79.80% of the stock is currently owned by institutional investors and hedge funds.

Shares of NASDAQ:IBB traded up $1.04 during trading on Thursday, reaching $149.89. The company had a trading volume of 46,190 shares, compared to its average volume of 3,333,646. The stock’s fifty day moving average price is $154.90 and its 200 day moving average price is $152.85. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $109.36 and a fifty-two week high of $174.04.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: Average Daily Trade Volume – What It Means In Stock Trading

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.